Beam Therapeutics Announces Acquisition of Guide Therapeutics

Health and medicine

Home » Health and medicine

Amyris Announces Positive Pre-Clinical Results For COVID-19 RNA Vaccine Platform With Advantaged Manufacturing, Storage And Distribution Characteristics

EMERYVILLE, Calif., Feb. 22, 2021 /PRNewswire/ — Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier...

America, Your Diet Is Killing You: Why The Glucose Crisis Will Be Worse Than The Opioid Crisis

Protalix BioTherapeutics Completes Raise of Approximately $40 Million in Gross Proceeds

Anticipated PDUFA for PRX-102 in Fabry disease currently set for April 27, 2021 Company, with its Commercialization Partner, Chiesi, poised to commercialize PRX-102 Additional data and milestones expected throughout...

Autolus Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional ADSs

Notch Therapeutics Closes $85 Million Series A Financing to Develop Pipeline of Renewable Stem Cell-Derived Cancer Immunotherapies

AbbVie and Caribou Biosciences Announce Collaboration and License Agreement for CAR-T Cell Products

Synlogic Appoints Lisa Kelly-Croswell to its Board of Directors

Cambrian Biopharma announces $60M in financing to develop a pipeline of companies and therapeutics to treat diseases of aging, coupled with a unique operational strategy

Nesos Announces Peer-Reviewed Validation Of Its First-of-its-Kind Wireless Earbud for the Treatment of Rheumatoid Arthritis

AbSci Enters Biologics Development Collaboration with Xyphos Biosciences, an Astellas Company

Joint Team from MIT and Synlogic Named a Biotechnology Grand Challenge Winner by Air Force Research Laboratory

Ginkgo Bioworks Selected to Provide Pooled COVID-19 Testing for Massachusetts K-12 Schools

Creo becomes first company to achieve demo scale production of rare cannabinoid CBGA

Lumen Bioscience Receives CARB-X Award to Develop Preventative for Deadly Diarrheal Diseases and Details Broad Potential of Spirulina Platform

Precigen Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares